Cheryl Day, PhD

Dr. Day received her B.S. degree in Biology from Emory University and her PhD in Virology from Harvard University. She was awarded a post–doctoral fellowship from the Royal Society in the United Kingdom to pursue research at the University of Oxford investigating the phenotype and function of HIV–specific CD8 T cells. She then transitioned to Durban, South Africa, and expanded her cellular HIV immunology studies to include TB/HIV co–infection. She subsequently joined the South African Tuberculosis Vaccine Initiative at the University of Cape Town to pursue research on T cell immunology in adults with latent Mycobacterium tuberculosis infection and active TB disease. Dr. Day is currently an Associate Professor in the Department of Microbiology and Immunology in the Emory University School of Medicine, and a faculty member in the Emory Vaccine
Center. She is also Director of the Emory Immunology Specialty Laboratory for the ACTG network and a member of the Cross–Network TB Vaccine Working Group. The research in her laboratory focuses on analysis of antigen–specific T cell and NK cell correlates of protection in cohorts of infants, children, and adults with HIV, TB, and TB/HIV co–infection.